Yixinningshen tablet and its preparation method

A technology of Yixin Ningshen Tablets and Shen Tablets, which is applied in the fields of medical formulas, nervous system diseases, and medical preparations containing active ingredients, etc., which can solve neurasthenia with insufficient curative effect, large side effects of chemically synthesized drugs, and financial burden on patients and other problems, to achieve the effect of high drug utilization, fast onset, and convenient administration

Inactive Publication Date: 2007-08-08
LIAONING HUANREN PHARMA
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, chemical synthetic drugs are mostly used for treatment. The disease is protracted and lingering for a long

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Yixin Ningshen Tablet and its preparation method, take 10g of total saponins from stems and leaves of ginseng, 1000g of Albizia vine, 500g of schisandra chinensis, and 500g of Ganoderma lucidum, grind schisandra chinensis into coarse powder, add 75% ethanol for 30 minutes, reflux extraction twice, the first 2.5 hours for the first time, 2 hours for the second time, combine the extracts, recover ethanol, concentrate to a thick paste, take the two flavors of Albizia juniper and Ganoderma lucidum, add water to decoct twice, the first time for 2 hours, the second time for 1.5 hours, filter After that, combine the filtrates and concentrate to a thick paste, take the above thick paste, combine, dry, and pulverize into fine powder, add ginseng stem and leaf total saponins and starch 90g, mix well, granulate with 35% ethanol or 10% syrup, and dry . Add 0.8% magnesium stearate and 1% talcum powder after granulation, mix evenly, press into 1000 tablets with a base tablet weight o...

Embodiment 2

[0056] Embodiment 2 is basically the same as Embodiment 1, except that the auxiliary materials added are calcium sulfate 16g, pregelatinized starch 14g, and starch 60g, mixed well, granulated with 40% ethanol or 10 syrup, and dried. Add 0.5% magnesium stearate and 1% talcum powder after granulation, mix, press to form 1000 tablets with a base tablet weight of 0.3g, and film coat to make each tablet weigh 0.31g film-coated tablets.

[0057] Usage and dosage: Take orally, 5 tablets each time, 3 times a day.

Embodiment 3

[0059] Embodiment 3 is basically the same as Embodiment 1, except that the auxiliary materials added are calcium sulfate 18g, pregelatinized starch 12g, and starch 58g, mixed evenly, granulated with 45% ethanol or 10% syrup, and dried. Add 0.5% magnesium stearate and 1% talcum powder after granulation, mix evenly, press into 600 tablets with a base tablet weight of 0.5g, and film coat to make each tablet weigh 0.52g film-coated tablets.

[0060]Dosage: Take orally, 3 tablets each time, 3 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for preparing relieving mental stress tablet, which comprises 9-11g panaxoside, 995-1005g albizia flower, 495-505g schisandra fruit, and 495-505g lucid ganoderma; breaks the schisandra fruit into rough powder, adding 75% alcohol to be immerged for 30min, refluxing and extracting for two times while the first time costs 2.5h and the second time costs 2h, combining the extractive and recycling alcohol, concentrating into dense paste; adding water into albizia flower and lucid ganoderma to be boiled for two times, while the first costs 2h and the second costs 1.5h; filtering, combining the fluid liquors, concentrating into dense paste, combining the dense pastes, drying and breaking into fine powder, adding panaxoside, and 80-100g amidon, or adding 15-20g calcium sulfate, 10-15g pre-gelatinized amidon, and 55-65g amidon; using 35-55% alcohol or 8-15% syrup to prepare particles, drying, and adding 0.5-1% dolomol and 1% French chalk, mixing uniformly, pressing into 1000 tablets or 600 tablets, coating sugar package or film. The invention has high drug utilization without side effect.

Description

technical field [0001] The invention relates to a Chinese patent medicine, in particular to a Yixin Ningshen tablet for treating palpitations, insomnia and forgetful neurasthenia and a preparation method thereof. Background technique [0002] Neurasthenia is a clinically common disease. Its pathogenesis is caused by the interaction of several pathogenic factors, which leads to the disturbance of the excitation and inhibition process of normal cranial nerves. The clinical manifestations are palpitations, insomnia, and forgetfulness. The theory of traditional Chinese medicine believes that it is a deficiency of the heart and spleen, and stagnation of liver and qi. It is mostly due to fatigue and thinking too much, which damages the heart and spleen. . At present, chemical synthetic drugs are mostly used for treatment. The disease is protracted and lingering for a long time. The chemical synthetic drugs used have large side effects and lack of pertinence. financial burden on ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/57A61K9/28A61P25/20
Inventor 郑继宇吴永军崔小路
Owner LIAONING HUANREN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products